Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy.
Ipp E, Liljenquist D, Bode B, Shah VN, Silverstein S, Regillo CD, Lim JI, Sadda S, Domalpally A, Gray G, Bhaskaranand M, Ramachandra C, Solanki K; EyeArt Study Group. Ipp E, et al. Among authors: liljenquist d. JAMA Netw Open. 2021 Nov 1;4(11):e2134254. doi: 10.1001/jamanetworkopen.2021.34254. JAMA Netw Open. 2021. PMID: 34779843 Free PMC article. Clinical Trial.
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, Simmons JH, Wadwa RP, Weinstock RS, Willi SM, Miller KM; CGM Intervention in Teens and Young Adults with T1D (CITY) Study Group; CDE10. Laffel LM, et al. Among authors: liljenquist d. JAMA. 2020 Jun 16;323(23):2388-2396. doi: 10.1001/jama.2020.6940. JAMA. 2020. PMID: 32543683 Free PMC article. Clinical Trial.
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Garg SK, Liljenquist D, Bode B, Christiansen MP, Bailey TS, Brazg RL, Denham DS, Chang AR, Akturk HK, Dehennis A, Tweden KS, Kaufman FR. Garg SK, et al. Among authors: liljenquist d. Diabetes Technol Ther. 2022 Feb;24(2):84-92. doi: 10.1089/dia.2021.0182. Epub 2021 Sep 9. Diabetes Technol Ther. 2022. PMID: 34515521 Free PMC article.
Control-IQ Technology Use in Individuals With High Insulin Requirements: Results From the Multicenter Higher-IQ Trial.
Carlson AL, Graham TE, Akturk HK, Liljenquist DR, Bergenstal RM, Sulik B, Shah VN, Sulik M, Zhao P, Briggs P, Sassan-Katchalski R, Pinsker JE. Carlson AL, et al. Among authors: liljenquist dr. J Diabetes Sci Technol. 2024 Mar 5:19322968241234072. doi: 10.1177/19322968241234072. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 38439656
An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1c.
Beck RW, Bocchino LE, Lum JW, Kollman C, Barnes-Lomen V, Sulik M, Haller MJ, Bode B, Cernich JT, Killeen AA, Garg U, Liljenquist D, Adams JG, Clements M, Gabrielson D, Johnson T, Clements MA. Beck RW, et al. Among authors: liljenquist d. Diabetes Technol Ther. 2021 Aug;23(8):537-545. doi: 10.1089/dia.2021.0023. Epub 2021 Apr 7. Diabetes Technol Ther. 2021. PMID: 33826420
Accuracy of Three Commercial Home-Use Hemoglobin A1c Tests.
Jacobsen LM, Bocchino LE, Lum JW, Kollman C, Barnes-Lomen V, Sulik M, Haller MJ, Bode B, Cernich JT, Killeen AA, Garg U, Liljenquist D, Adams JG, Clements M, Gabrielson D, Johnson T, Clements MA, Beck RW. Jacobsen LM, et al. Among authors: liljenquist d. Diabetes Technol Ther. 2022 Nov;24(11):789-796. doi: 10.1089/dia.2022.0187. Diabetes Technol Ther. 2022. PMID: 35763337
49 results